Share

April 11, 2017; 88 (15) ArticleOpen Access

Intracerebral hemorrhage location and outcome among INTERACT2 participants

Candice Delcourt, Shoichiro Sato, Shihong Zhang, Else Charlotte Sandset, Danni Zheng, Xiaoying Chen, Maree L. Hackett, Hisatomi Arima, Jun Hata, Emma Heeley, Rustam Al-Shahi Salman, Thompson Robinson, Leo Davies, Pablo M. Lavados, Richard I. Lindley, Christian Stapf, John Chalmers, Craig S. Anderson, For the INTERACT2 Investigators
First published February 24, 2017, DOI: https://doi.org/10.1212/WNL.0000000000003771
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
6298

Share

Article Information

vol. 88 no. 15 1408-1414
DOI: 
https://doi.org/10.1212/WNL.0000000000003771
PubMed: 
28235817
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received August 2, 2016
  • Accepted in final form January 18, 2017
  • First Published February 24, 2017.

Article Versions

Copyright & Usage: 
Copyright © 2017 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution License 4.0 (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Author Disclosures

    1. Candice Delcourt, MD*,
    2. Shoichiro Sato, MD, PhD*,
    3. Shihong Zhang, MD, PhD,
    4. Else Charlotte Sandset, MD, PhD,
    5. Danni Zheng, PhD,
    6. Xiaoying Chen, BPharm, BMgt,
    7. Maree L. Hackett, PhD,
    8. Hisatomi Arima, MD, PhD,
    9. Jun Hata, MD, PhD,
    10. Emma Heeley, PhD,
    11. Rustam Al-Shahi Salman, MD, PhD,
    12. Thompson Robinson, MD, PhD,
    13. Leo Davies, MD,
    14. Pablo M. Lavados, MD, MPH,
    15. Richard I. Lindley, MD, PhD,
    16. Christian Stapf, MD, PhD,
    17. John Chalmers, MD, PhD,
    18. Craig S. Anderson, MD, PhD;
    19. For the INTERACT2 Investigators
  1. Candice Delcourt, MD*,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Shoichiro Sato, MD, PhD*,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Shihong Zhang, MD, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Else Charlotte Sandset, MD, PhD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. European Stroke Journal, Editorial Board member, 2016-

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Post-doctoral fellowship - South-Eastern Regional Health Authority 2016-2018 - Grant number: 2015068

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Danni Zheng, PhD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. The University of Sydney

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Xiaoying Chen, BPharm, BMgt,
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Maree L. Hackett, PhD,
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Boehringer Ingelheim, reimbursement for travel expenses

    Editorial Boards:

    1. Cochrane Stroke Group, Associate Editor, 1 year Cochrane Stroke Group, Editorial Board Member, 6 years

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. National Heart Foundation, Future Leader Fellowship 2014- 2017, Level 2 #100034

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Google

    Research Support, Government Entities:

    1. National Health and Medical Research Council, Australia Swedish Research Council Framework, Sweden National Institute for Health Research, United Kingdom

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. National Heart Foundation, Australia Cochrane Chest, Heart and Stroke, Scotland

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Hisatomi Arima, MD, PhD,
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1) Journal of Hypertension, Editorial Board Member, 2 year, (2) BMC Public Health, Associate Editor, 4 years, (3) Journal of Epidemiology, Associate Editor, 1 year

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. Takeda Pharmaceutical Company

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NHMRC Project Grant, 1020462, Chief Investigator, 2012- 2016

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. Jun Hata, MD, PhD,
    10. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  10. Emma Heeley, PhD,
    11. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) The Australian National Health and Medical Research Council, project grant funding 2014-2016 for the Sleep Apnea and cardioVascular Endpoint study. (grant number 1060078) EH was an investigator on the grant.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  11. Rustam Al-Shahi Salman, MD, PhD,
    12. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1) Cochrane Stroke Group, editor, 2009-present (2) Evidence-based Preclinical Medicine, senior editor, 2014- present (3) Trials, senior editor, 2016-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. UK Medical Research Council senior clinical fellowship (G1002605), 2011-2016. British Heart Foundation travel fellowship (FS/13/72/30531), 2013-2014.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  12. Thompson Robinson, MD, PhD,
    13. Scientific Advisory Boards:

    1. Commercial (Daiichi Sankyo), Advisory Board. Commercial (Boehringer Ingelheim), Advisory Board.

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Age and Ageing, Associate Editor, 2003 to 2016

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Research Council (EPSRC) 2013 (3 Years, Principal Applicant); Diversity in blood flow control of the brain: moving from individual modelling towards personalised treatment of the injured brain (?320,853) NIHR Health Technology Assessment Programme Clinical Trials 2012 (5 years, Co-applicant); Safety and Efficacy of Triple Antiplatelets for Reducing Dependency After Ischaemic Stroke: the TARDIS Randomied Controlled Trial (?3,291,971) NIHR Health Technology Assessment Programme Clinical Trials 2012 (4 years, Co-applicant); Tranexamic acid for hyperacute primary Intracerebral Haemorrhage, TICH-2 (?2,889,221) NIHR Programme Grant 2012 (5 years, Co-Applicant): Bridging the age gap in breast cancer. Improving outcomes for older women. (?1,705,273) NIHR Senior Investigator 2016 (3 years, Principal Applicant): NIHR Senior Investigator. (?45,000)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Stroke Association/British Heart Foundation Programme Grant 2012 (5 years, Principal Applicant); Blood Pressure Variability ? Definition, Natural History, Prognosis and Treatment Following Acute Stroke (?878,190) The Stroke Association 2012 (3 years, Principal Applicant); Enhanced Control of Hypertension and Thrombolysis Stroke Trial, ENCHANTED (?202,319) British Heart Foundation 2010 (3 years, Co-applicant); Intermediate Basic Science Research Fellowship: Forecasting brain injury in the virtual patient (?259,268) Stroke Association 2009 (2 years, Principal Applicant); Project Grant: MRI Assessment of Post-Stroke Focal Versus Global Cerebrovascular Autoregulation (?102,332) British Heart Foundation 2008 (3 years, Co-applicant); Project Grant: Safety and tolerability of adding clopidogrel to aspirin and dipyridamole in patients with acute ischaemic stroke or TIA: a randomised controlled trial (?318,932)

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  13. Leo Davies, MD,
    14. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  14. Pablo M. Lavados, MD, MPH,
    15. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. 1. Bayer: Received travel grant by Bayer for the ?andu study. 2. Received speaker honoraria from Bayer

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. 1. Clinica Alemana, Universidad del Desarrollo: Receives institutional support from Clinica Alemana, Universidad del Desarrollo to perform stroke administration and research.

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. 1. Boerhinger Ingelheim: Receives research funding for the ?andu study. 2. Astra Zeneca: Served as national leader of SOCRATES study and receives research funding for this. 3. Bayer: Serves as the National leader of the NAVIGATE ESUS trial.

    Research Support, Government Entities:

    1. CONICYT: Recieved research grant for the ?andu proyect.

    Research Support, Academic Entities:

    1. 1. Clinica Alemana-Universiad del Desarrollo: Receives academic research support from Cl?nica Alemana for the HEADPOST studies. 2. The George Institute for Global Health. Receives academic research support from TGI for the INTERACT2, ENCHANTED and HEADPOST studies.

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  15. Richard I. Lindley, MD, PhD,
    16. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. I am an Associate Editor for the Australasian Journal on Ageing, not compensated.

    Patents:

    1. NONE

    Publishing Royalties:

    1. Stroke: The Facts. Lindley RI. Oxford University Press 2008. ISBN 978-0-19-921272-9 Understanding Stroke. Lindley RI. The British Medical Association Family Doctor Series. ISBN: 1 898205 60 4. Published by Family Doctor Publications Ltd in association with the British Medical Association 2000. Second edition 2002. Third Edition 2003. Fourth edition 2005.

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1) INTERACT: a randomised trial of intensive blood pressure lowering in acute intracerebral haemorrhage. Anderson C, Chalmers J, Wang J, Lindley R. 2) NHMRC (Australia) Project Grant 512402;Chief Investigator 2008-11. 3) NHMRC (Australia) Partnership Grant 569328, Chief Investigator, 2010-2014. 4) NHMRC (Australia) Project Grant APP1004170, Chief Investigator 2011-13. 5) NHMRC (Australia) Project Grant, APP1020462 Chief Investigator, 2012-2015 6) NHMRC (Australia) Project Grant, APP1024440, Chief Investigator, 2012-14 7) NHMRC (Australia) Project Grant, APP1041401, Chief Investigator 2013-6 8) NHMRC (Australia) Project Grant. APP1045391 Chief Investigator, 2013-6 9) NHMRC (Australia) Project Grant,APP1063751 Chief Investigator, 2014-6 10) NHMRC (Australia) Project Grant, APP1101113 Chief Investigator, 2016-8

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  16. Christian Stapf, MD, PhD,
    17. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH/NINDS, NS051483-01A1, co-PI, 2006-2014

    Research Support, Academic Entities:

    1. (1) Columbia University New York, USA; (2) University Paris Diderot - Sorbonne Paris Cit?, France

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  17. John Chalmers, MD, PhD,
    18. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Research grants from Servier for the ADVANCE-ON post trial follow-up study and, and honoraria and travel support from Servier, for speaking about the ADVANCE and ADVANCE-ON studies at Scientific meetings

    Editorial Boards:

    1. Associate Editor for the Journal of Hypertension, from 2011

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. The National Health and Medical Research Council of Australia has awarded me two project grants (1) as Co- Chief Investigator for INTERACT2 for 2008-2011 : Grant number 512402:2008-2011, and (2) as Co-Chief Investigator for ENCHANTED for 2012-17 : Grant Number APP1020462.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  18. Craig S. Anderson, MD, PhD;
    19. Scientific Advisory Boards:

    1. Astra Zeneca and Medtronic

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Receives honoraria and for travel from Takeda China and Boehringer Ingelheim

    Editorial Boards:

    1. Stroke, Cerebrovascular Diseases, International Journal of Stroke

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Program grant (1052555), Project grant (1020462) and Fellowship (1081356) support from the National Health and Medical Research Council (NHMRC) of Australia.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  19. For the INTERACT2 Investigators
    1. From The George Institute for Global Health and The University of Sydney (C.D., S.S., E.C.S., D.Z., X.C., M.L.H., E.H., R.I.L., J.C., C.S.A.); Royal Prince Alfred Hospital (C.D., L.D., J.C., C.S.A.), Camperdown, Australia; National Cerebral and Cardiovascular Center (S.S.), Osaka, Japan; Department of Neurology (S.Z.), West China Hospital, Sichuan University, Chengdu; Oslo University Hospital (C.S.), Norway; The University of Central Lancashire (M.L.H.), UK; Department of Preventive Medicine and Public Health (H.A.), Faculty of Medicine, Fukuoka University; Center for Cohort Studies (J.H.), Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Division of Clinical Neurosciences (R.A.-S.S.), Centre for Clinical Brain Sciences, University of Edinburgh; Department of Cardiovascular Sciences and NIHR Biomedical Research Unit for Cardiovascular Diseases (T.R.), University of Leicester, UK; Clínica Alemana de Santiago (P.M.L.), Facultad de Medicina Clinica Alemana Universidad del Desarrollo; Facultad de Medicina (P.M.L.), Universidad de Chile, Santiago; Westmead Hospital Clinical School (R.I.L.), Westmead, Australia; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM) (C.S.), Département de Neurosciences, Université de Montréal, Canada; and The George Institute China (C.S.A.), Peking University Health Sciences Center, Beijing, China.
    1. Correspondence to Dr. Anderson: canderson{at}georgeinstitute.org.au
    View Full Text

    Article usage

    Article usage: February 2017 to December 2022

    AbstractFullPdfSource
    Feb 20171055054Highwire
    Mar 201727080210Highwire
    Apr 2017278975211Highwire
    Apr 2017163033pmc
    May 2017348316145Highwire
    May 2017305963pmc
    Jun 20171395152Highwire
    Jun 2017234041pmc
    Jul 20171185062Highwire
    Jul 2017184242pmc
    Aug 2017712794Highwire
    Aug 2017122731pmc
    Sep 2017493862Highwire
    Sep 2017163937pmc
    Oct 2017461235Highwire
    Oct 2017153235pmc
    Nov 2017661945Highwire
    Nov 2017103139pmc
    Dec 2017132841Highwire
    Jan 2018114864Highwire
    Feb 201863527Highwire
    Mar 201834836Highwire
    Apr 201854948Highwire
    Apr 2018135251pmc
    May 2018115736Highwire
    Jun 201847032Highwire
    Jun 201863839pmc
    Jul 2018126741Highwire
    Aug 201827262Highwire
    Aug 2018156368pmc
    Sep 201856769Highwire
    Oct 2018710184Highwire
    Nov 2018311054Highwire
    Dec 2018410046Highwire
    Jan 2019513648Highwire
    Feb 2019712350Highwire
    Mar 201919374Highwire
    Apr 201948066Highwire
    May 201979889Highwire
    Jun 201917572Highwire
    Jul 201938680Highwire
    Aug 2019711585Highwire
    Sep 201947055Highwire
    Oct 2019510097Highwire
    Nov 2019511488Highwire
    Dec 2019610392Highwire
    Jan 2020511493Highwire
    Feb 2020710290Highwire
    Mar 2020911181Highwire
    Apr 202056597Highwire
    May 20205100109Highwire
    Jun 202048692Highwire
    Jul 202011110123Highwire
    Aug 2020107784Highwire
    Sep 20201387106Highwire
    Oct 202042175124Highwire
    Nov 2020697129Highwire
    Dec 20201785117Highwire
    Jan 20211082112Highwire
    Feb 20211473103Highwire
    Mar 202112123165Highwire
    Apr 202113107125Highwire
    May 202113132116Highwire
    Jun 20218143137Highwire
    Jul 20211687149Highwire
    Aug 2021206482Highwire
    Sep 202117110113Highwire
    Oct 2021108499Highwire
    Nov 202198192Highwire
    Dec 202157557Highwire
    Jan 202257378Highwire
    Feb 202297762Highwire
    Mar 202289089Highwire
    Apr 202256867Highwire
    May 202288457Highwire
    Jun 2022510679Highwire
    Jul 20221310346Highwire
    Aug 202297542Highwire
    Sep 2022117152Highwire
    Oct 2022108445Highwire
    Nov 20221510566Highwire
    Dec 202249135Highwire

    Cited By...

    Letters: Rapid online correspondence

    No comments have been published for this article.
    Comment

    REQUIREMENTS

    If you are uploading a letter concerning an article:
    You must have updated your disclosures within six months: http://submit.neurology.org

    Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

    If you are responding to a comment that was written about an article you originally authored:
    You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
    and apply to letter.

    Submission specifications:

    • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
    • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
    • Submit only on articles published within 6 months of issue date.
    • Do not be redundant. Read any comments already posted on the article prior to submission.
    • Submitted comments are subject to editing and editor review prior to posting.

    More guidelines and information on Disputes & Debates

    Compose Comment

    More information about text formats

    Plain text

    • No HTML tags allowed.
    • Web page addresses and e-mail addresses turn into links automatically.
    • Lines and paragraphs break automatically.
    Author Information
    NOTE: The first author must also be the corresponding author of the comment.
    First or given name, e.g. 'Peter'.
    Your last, or family, name, e.g. 'MacMoody'.
    Your email address, e.g. higgs-boson@gmail.com
    Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
    Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
    Publishing Agreement
    NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

    Vertical Tabs

    You May Also be Interested in

    Back to top

    More Online

    CME Course

    Topics Discussed

    Alert Me